SavedAdd your journal

Journals / Yeni Tıp Dergisi / 2009 / Cilt: 26 - Sayı: 4

Cushing’s syndrome depend on by a long term used topical steroid therapy for in adult psoriasis

Erişkinde uzun süreli potent topikal steroid kullanımına bağlı cushing sendromu

Feridun KARAKURT
Ayşe ÇARLIOĞLU
Özgür ATMACA
Seval ERPOLAT
Benan KASAPOĞLU
Pages
239–240
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, clobetasol propionate ointment doses exceeding 50 g a week should not be prescribed and use of occlusive dressings should be avoided.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 32-year-old man developed manifestations of Cushing’s syndrome after long-term topical steroid therapy for psoriasis.
📊
Key Findings & Data:Considering their serious consequences physicians should be carefully to signs of Cushing’s syndrome in patients on long-term topical steroid therapy.
💡
Conclusion & Impact:Furthermore, clobetasol propionate ointment doses exceeding 50 g a week should not be prescribed and use of occlusive dressings should be avoided.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 32-year-old man developed manifestations of Cushing’s syndrome after long-term topical steroid therapy for psoriasis. There have only been a few reports of systemic side effects of topically applied corticosteroids. Considering their serious consequences physicians should be carefully to signs of Cushing’s syndrome in patients on long-term topical steroid therapy. Furthermore, clobetasol propionate ointment doses exceeding 50 g a week should not be prescribed and use of occlusive dressings should be avoided.

Özet

Otuz iki yaşında bir erkek hasta psöriazis nedeniyle uzun süre topikal steroid kullanımına bağlı Cushing sendromu kliniği ile başvurdu. Topikal steroid kullanımına bağlı sistemik yan etkiler seyrek vakalar halinde literatürde bildirilmiştir. Uzun süreli topikal steroid kullanan hasta-larda ciddi yan etkilerin olabileceği konusunda hekim her zaman dikkatli olmalıdır. Ayrıca klobetasol propiyonat pomat haftada 50 gramı aşacak şekilde reçete edilme-meli ve tüm vücudu saracak şekilde uygulanmamalıdır.

🔖

Cite This Article

KARAKURT, F., ÇARLIOĞLU, A., ATMACA, Ö., ERPOLAT, S., KASAPOĞLU, B. (2009). Cushing’s syndrome depend on by a long term used topical steroid therapy for in adult psoriasis. Yeni Tıp Dergisi, Cilt: 26 - Sayı: 4, 239–240. https://ajindex.com/articles/338329

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Schweizer DH, Le-Brun PPH, Krishnaswami S, Derendorf H. Clinical and pharmacological aspects of accidental triamcinolone acetonide overdosage: a case study. Neth J Med 2000;56: 12-6
  2. Tsuruoka S, Sugimoto K, Fujimura A. Drug-induced Cushing’s syndrome in a patient with ulcerative colitis after betamethasone enema: evaluation of plasma drug concentration. Ther Drug Monit 1998;20: 387-9
  3. Staughton RCD, August PJ. Cushing’s syndrome and pituitary-adrenal suppression due to clobetasol propionate. BMJ 1975;2: 419-21
  4. Allenby CF, Main RA, Marsden RA, Sparkes CG. Effect on adrenal function of topically applied clobetasol propionate (Dermovate). BMJ 1975;4: 619-21
  5. Kelly A, Nelson K, Goodwin M, McCluggage J. Iatrogenic Cushing’s syndrome. BMJ 1972;4: 114
  6. Himathongkam Th, Dasanabhairochana P, Pitchayayothin N, Sriphrapradang A. Florid Cushing’s syndrome and hirsutism induced by desoximetasone. JAMA 1978;239: 430-1
  7. Ohnishi T, Suzuki T, Watanabe S, Takahashi H. Erythrodermic psoriasis associated with hyperuricemia and iatrogenic Cushing’s syndrome due to topical corticosteroid therapy. Int J Dermatol 1996;35: 379-80
  8. Teelucksingh S, Bahall M, Coomansingh D, Suite M, Bartholomew C. Cushing’s syndrome from topical glucocorticoids. West Indian Med J 1993;42: 77-8
  9. Barnetson RS, White AD. The use of corticosteroids in dermatological practice. Med J Aust 1992;156: 428-31
  10. Young CA, Williams IR, MacFarlane IA. Unrecognised Cushing’s syndrome and adrenal suppression due to topical clobetasol propionate. Br J Clin Pract 1991;45: 61-2
  11. Dhein S. Cushing syndrome following external glucocorticoid administration in psoriasis. Z Hautkr 1986;61: 161-6
  12. Ruiz-Maldonado R, Zapata G, Tamayo L, Robles C. Cushing’s syndrome after topical application of corticosteroids. Am J Dis Child 1982;136: 274-5
  13. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C. Potential hazards of topical steroid therapy. Am J Dis Child 1983;137: 1130-1
  14. Turpeinen M, Salo OP, Leisti S. Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 1986;115: 475-84
  15. Curtis JA, Cormode E, Laski B, Toole J, Howard N. Endocrine complications of topical intralesional corticosteroid therapy. Arch Dis Childhood 1982;57: 204-7
  16. Williams GH, Dluhy RG. Diseases of the adrenal cortex. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. eds. Harrison’s Principles of internal medicine. 14t